| Antiviral Research | |
|---|---|
| Abbreviated title (ISO) | 'Antiviral Res' |
| Discipline | Antivirals |
| Language | English |
| Publication details | |
| Publisher | Elsevier (The Netherlands) |
| Publication history | 1981–present |
| Frequency | 12 per year |
| Open access | none |
| Impact factor (2009) |
3.612 |
| Indexing | |
| ISSN | 0166-3542 |
| Links | |
Antiviral Research is a peer-reviewed academic journal published monthly by Elsevier from Amsterdam, The Netherlands. Founded in 1981, the journal is an official publication of the International Society for Antiviral Research.
Antiviral Research publishes research articles and reviews on all aspects of the development of drugs, vaccines and immunotherapies against viruses of animals and plants, including chemistry, virology, mechanism of action, in vitro activity, animal models and clinical trials. The journal also covers host resistance to viral infection.
Content from the first issue is available online in PDF and text formats via ScienceDirect; access is by subscription only.
The journal's 2007 impact factor was 3.358.[1] Antiviral Research is indexed in Abstracts on Hygiene and Communicable Diseases, BIOBASE, BIOSIS, Current Contents (Life Sciences), EMBASE, Medline, Pascal et Francis, Reference Update, Science Citation Index, Scopus and Tropical Diseases Bulletin.
As of 2007, the Editors-in-Chief are Erik de Clercq (Rega Institute, Leuven, Belgium), Earl R. Kern (University of Alabama at Birmingham, Birmingham, USA) and Richard J. Whitley (University of Alabama at Birmingham, Birmingham, USA).